Abstract. The aim of the present study was to determine the long-term outcomes of bifurcation lesions following a rotational atherectomy (ROTA). In this retrospective study, patients that had undergone a ROTA of the bifurcation coronary lesions in Juntendo University Hospital (Tokyo, Japan) were enrolled between January 2007 and December 2009, and received follow-up for a median duration of 48 months (range, 12-84 months). A total of 337 patients were enrolled. Each patient was treated with an average of 1.2±0.4 ROTA burrs (mean size, 2.9±0.3 mm). Baseline lesion length, reference diameter, minimal lumen diameter (MLD) and percentage of diameter stenosis (%DS) prior to the procedure were comparable between the DM and non-DM patients. Furthermore, MLD, %DS and acute gain following the procedure were similar between the two groups. At follow-up, DM patients exhibited a significantly decreased MLD ( Although the usage of ROTA and drug-eluting stent evidently improved long-term outcomes in patients with bifurcation lesions, DM remained an independent risk factor for TLR, TL restenosis and MACE. Therefore, the management of DM in bifurcation lesions treated with ROTA requires increased investigation in future clinical practice.
Introduction
Coronary bifurcation lesions represent a complex lesion subtype, and treatment via a percutaneous coronary intervention (PCI) has been associated with reduced procedural success rates, an increased rate of restenosis and major adverse cardiovascular events (MACE) (1) (2) (3) (4) . In previous decades, considerable progress has occurred in the field of PCI, including the use of plaque debulking [rotational atherectomy (ROTA) or directional atherectomy and ablative lasers], cutting balloon, bare-metal stents (BMS), and particularly the development of drug-eluting stents (DES) (5) (6) (7) (8) . Previous studies have indicated that DES are able to significantly improve the incidence of myocardial infarction (MI), target vessel revascularization (TVR) and MACE following PCI of bifurcation coronary lesions, compared with BMS (9) (10) (11) (12) . Despite advances in device technology, the treatment of coronary bifurcation lesions remains a technically challenging field. An alternative to PCI is the coronary artery bypass graft; however, PCI is preferred due to minimal invasion (13) .
It has been estimated that bifurcation lesions comprise 15-20% of all PCI procedures (14, 15) . Stenting of a bifurcation lesion may result in a significant reduction in the angiographic diameter of the ostium of the side branch (SB), primarily as a result of plaque shifting, ostial recoil and propagation of dissection (16, 17) . ROTA has been advocated for the treatment of bifurcation lesions as it appears to effectively remove plaque while minimizing injury to adjacent normal arterial segments to a greater extent compared with standard balloon angioplasty (BA), while additionally avoiding 'snow' plaque shifting (18, 19) . However, the role and long-term outcomes of ROTA for the treatment of bifurcation coronary lesions in the DES era remain unknown and require further investigation. Diabetes mellitus (DM) is a major contributor to the development of coronary artery disease (CAD) as well as to the outcomes following various manifestations of the disease. DM patients have a higher prevalence of complex coronary lesions such as triple-vessel, bifurcation and ostial lesions. Therefore, the aim of the present study was to determine the long-term outcomes of bifurcation lesions following a ROTA. (20) . All coronary angiograms obtained from the study patients were reviewed by board-certified interventional cardiologists.
Materials and methods

Study
Diabetes mellitus (DM) was defined as the patient receiving active treatment with insulin or an oral antidiabetic agent, or if the patient exhibited an abnormal blood glucose level following overnight fasting or abnormal glucose tolerance test results according to the World Health Organization criteria (21) . The patients were divided into DM and non-DM groups.
Procedures. All baseline, procedural, and follow-up angiograms were performed immediately following the administration of 200 µg intracoronary nitroglycerin, and the treated lesion was evaluated using two or more angiographic projections. The Cardiovascular Measurement System (Medis Medical Imaging Systems, Leiden, Netherlands) was used by two experienced angiographers to perform quantitative coronary angiography. The reference diameter, lesion length, % of diameter stenosis (%DS) and minimal lumen diameter (MLD) were measured using the view showing the smallest luminal diameter in the diastolic frames.
Lesions were classified according to the modified American College of Cardiology/American Heart Association grading system as type A, B1, B2 or C (22) . Type A and B1 lesions were categorized as simple, while type B2 and C lesions were designated complex. The degree of coronary calcification was judged as follows: Grade 1, calcification difficult to recognize; grade 2, easily recognized; grade 3, recognized in >50% of a single coronary artery; and grade 4, recognized in nearly the entire length of a single coronary artery.
Louvard et al (23) defined a bifurcation lesion as 'a coronary artery narrowing occurring adjacent to, and/or involving, the origin of a significant SB'. A significant SB was defined as a branch (typically with a diameter of >1.5 mm) that would result in detrimental effects if lost, due to the associated symptoms, location of ischemia and loss of viability, collateral vessels and ventricular function (23) . The diameter of SB was classified as small (≤2.0 mm), medium (2.0-2.5 mm) or large (≥2.5 mm). Lesion angulation was measured at baseline in a working view, which provided the optimal SB ostium visualization, by measuring the distal angle between the SB and the main vessel (MV) distal to the bifurcation. When angulation was <70˚, the bifurcation lesion was defined as Y-shape, while bifurcation lesions with angulation of >70˚ were defined as T-shape. The bifurcation lesion type was classified according to the classification of Medina et al (24) .
A true bifurcation coronary lesion was defined as a coronary lesion with ≥50% luminal diameter stenosis in the parent vessel and the ostium of an SB arising from the lesion, which were observed to be ≥2.0 mm in diameter by visual estimation, in addition to specific plaque geography meeting the Medina classification (24), as follows: (1,1,1), (1,0,1), (0,1,1).
A simple stenting strategy was defined as stenting of the MV only, and provisional stenting of the SB only if bailout of the SB was necessary, while a complex stenting strategy was defined as routine stenting in the MV and SB using a variety of techniques, including crush, mini-crush, modified crush, culotte, simultaneous kissing stent and T-stent (25) .
Events. Acute gain and late loss were defined as the difference between pre-and post-procedural MLD, and between post-procedural and follow-up MLD. Procedural success was defined as the achievement of <30% angiographic residual stenosis in the MV, <50% in the SB by quantitative coronary angiography and thrombolysis in MI flow grade 3 in the MV and SB, with no periprocedural or in-hospital complications such as mortality, MI or emergent bypass surgery. MI was defined as the MB isoform of creatine kinase level was >3 times the normal value, with or without the occurrence of new abnormal Q-waves in ≥2 contiguous leads.
Acute thrombosis was defined as the occurrence of acute closure of the target vessel <24 h after the index procedure. Subacute thrombosis was defined as the occurrence of acute closure of the target vessel after 24 h but within 1 month, and late thrombosis was defined as the occurrence of acute closure ≥1 month after the index procedure (26) .
Angiographic evaluations were performed at regular intervals. In addition, a repeat coronary angiography was scheduled within 5-9 months after the index procedure, unless earlier intervention was required due to symptoms or a history of myocardial ischemia. Follow-up was discontinued after December 2010.
Target lesion (TL) restenosis was defined as a stenosis diameter of ≥50% within the stented segment and the 5-mm proximal and distal persistent area at follow-up angiography. In addition, TL revascularization (TLR) was defined as any revascularization or bypass surgery of the original TL, which was performed in the presence of angiographic restenosis of ≥50% by quantitative angiography in the presence of ischemic symptoms or objective evidence of ischemia, or in the presence of angiographic restenosis ≥70% with no evident ischemic symptoms or indications of ischemia. The TL was considered to be the area covered by the stent plus a 5-mm margin proximal and distal to the edges of the stent (27) . Furthermore, TVR was defined as clinically driven PCI or coronary artery bypass grafting of the treated vessel. MACE was defined as a composite of clinical events including TLR, TL restenosis, non-fatal MI (Q-or non-Q-wave MI), acute thrombosis, subacute thrombosis and cardiac fatality (27) .
Statistical analysis. Discrete variables are presented as frequency counts and percentages. Continuous variables were expressed as the mean ± standard deviation when normally distributed, or as the median with interquartile range if not.
The χ 2 test, two-tailed independent Student's t-test and Wilcoxon/Kruskal-Wallis test were used to compare proportions and mean/median values. Independent predictors of long-term outcomes were identified using Cox's proportional hazards analysis and logistic regression analysis. Kaplan-Meier accumulated survival curves were drawn and log-rank values were calculated to assess their statistical significance.
Data analysis was performed using JMP software, version 8.0 (SAS Institute Inc., Cary. NC. USA). P≤0.05 was considered to indicate a statistically significant difference.
Results
Patient characteristics.
A total of 337 patients met the study criteria and were enrolled into the present study. The patients had a mean age of 68.1±9.1 years (age range, 52-86 years old), and 283 subjects (84.0%) were male. In total, 178 patients (52.8%) had a history of DM, 28 patients had a history of PCI and 39 patients were receiving hemodialysis treatment due to end-stage renal disease. Detailed baseline demographics and clinical risk factors in DM and non-DM patients are presented in Table I . Baseline patient characteristics were comparable between the two groups (P>0.05), with the exception of reduced eGFR and an increased number of hemodialysis patients in the DM group compared with the non-DM group. in the DM and non-DM patients were comparable (P>0.05) and are presented in Table II .
Quantitative coronary angiographic data in the two groups are presented in Table III Kaplan-Meier survival curves indicated that the rates of TLR and MACE were significantly higher in the non-DES group ( Fig. 1A and B ; log-rank P<0.0001) and DM group ( Fig. 2A and B ; log-rank P<0.05).
Multivariate Cox proportional hazard analysis (Table V) Data presented as the mean ± SD. All other fields presented as n (%). DM, diabetes mellitus; TLR, target lesion revascularization; TVR, target vessel revascularization; MI, myocardial infarction; SAT, subacute thrombosis; MACE, major adverse cardiovascular events. 
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DM (P=0.0053), current smoker status (P=0.0059) and DES stenting (P<0.0001) were independent predictors of TL restenosis at follow-up (Table VI) .
Discussion
The results of the present study indicated that in bifurcation lesions treated with ROTA, patients that have undergone non-DES and DM patients exhibited higher rates of TLR and MACE. Bifurcation coronary lesion represents a complex lesion subtype and remains a major interventional challenge, despite the advances associated with DES. The complexity of treating bifurcations arises from a number of technical and clinical challenges, including variations in bifurcation anatomy (different bifurcation location, type and angulation) and dynamic differences in anatomy during treatment (plaque shifting and dissection causing flow problems), as well as time-consuming and technically challenging managements, including wire trapping and subsequent requirement of wire replacement, stent deformation, incomplete lesion coverage, stent overlap and large metal burden in the arteries (2, 14, 15, 28) . Previous studies have indicate that DES is superior to BMS in the treatment of bifurcation lesions with lower in-stent restenosis or TLR (9, 11, 12, 29) . In the present study, significant reductions in TLR rates (15.7 vs. 5.0%; P=0.0011) and MACE rates (20.2 vs. 12.0; P=0.039) were observed in the DES group compared with the BA and BMS groups, and the use of DES was an independent protector for TLR and MACE. DES has emerged as the preferred stent platform for the treatment of coronary bifurcations. However, due to the aforementioned causes, PCI for bifurcation remains technically challenging, with reduced procedural success rates and worse clinical outcomes compared with non-bifurcation lesions, despite recent advances in interventional cardiology and the introduction of DES (30) .
ROTA may provide a safe and effective means of treating this difficult lesion subtype. ROTA is performed using a high-speed rotating burr containing diamond chips, which selectively ablates calcified plaque within the coronary artery while deflecting normal elastic tissue away from the burr, resulting in a near circular lumen with a focally smooth and polished surface (31, 32) . The small particles are able to pass harmlessly through the distal myocardial capillary bed (33) . This technique has been particularly useful for heavily calcified lesions that cannot be easily approached using BA or directional atherectomy (34) . In the present study, 62.6% of the subjects had severe calcified lesions (grade 3 or 4). A number of previous studies have reported the use of ROTA for the treatment of bifurcation lesions. Nageh et al (35) evaluated the role of ROTA in a non-randomized study and observed that the ROTA group exhibited a higher success rate and lower in-hospital event rate. Furthermore, during a mean follow-up period of 15 months, ROTA was associated with reduced cardiac events and target lesion revascularization compared with BA. Furthermore, Dauerman et al (36) compared the clinical outcomes between mechanical debulking (directional or rotational coronary atherectomy) and BA for true bifurcation lesions. At the 1-year follow-up, the incidence of TVR was markedly reduced in the debulking group compared with the BA group. In addition, Ito et al (28) have demonstrated the safety and feasibility of ROTA and provisional SB stenting to treat SB ostial lesions of true severe bifurcation coronary artery disease. The authors suggested that ROTA of an SB ostium prior to MV stenting may be performed in patients undergoing complex bifurcation lesion angiography (28) .
Based on the aforementioned findings of previous studies, the combination of ROTA and DES placement appears to be a promising approach for the treatment of bifurcation lesions. In the present study, which included a mean follow-up period of 52.2±19.4 months, the rates of TLR and MACE were 10.7 and 16.3%, respectively, in all cohorts, and 7.1 and 10.8% in DES group, respectively. Considering the extended period of follow-up, it appears to be a low incidence of TLR and MACE.
The results of previous studies have indicated that DM is a consistent clinical predictor of worse outcomes following BA, BMS and DES implantation (37) (38) (39) . Patients with DM exhibit a higher risk of mortality and elevated restenosis rates following stenting compared with patients without DM, despite the application of DES. In the present study, increased rates of TLR (15.7 vs. 5.0%; P=0.0011), target lesion restenosis (25.8 vs. 12.6%; P=0.0019) and MACE (20.2 vs. 12.0%; P=0.039) were observed in the DM group compared with the non-DM group. After adjusting for other factors, DM remained an independent risk factor of TLR, TL restenosis and MACE.
Diabetes is associated with hormonal and vascular abnormalities that promote the proliferation of smooth muscle cells after vascular injury, including injury from catheter-based interventions, including BA, stenting implantation and ROTA (40) . Increased smooth muscle proliferation in diabetic patients may by induced by mitogens, such as platelet-derived growth factor and insulin-like growth factor, that stimulate cell growth and deleterious vascular effects, including endothelial dysfunction and excessive extracellular matrix production (41) . In addition, DM is markedly associated with the loss of endothelial cells, increased platelet activation, hypercoagulability and the release of vasoconstrictive substances (42) . This may explain why DM remained the 'Achilles' heel' of bifurcation lesions following the introduction of DES and ROTA (43) . Therefore, patients with DM that receive ROTA and DES for bifurcation lesions may require adjunctive systemic pharmacotherapy to modify the underlying pathophysiological mechanisms responsible for neointimal formation and atherosclerosis progression. There were a number of limitations in the present study. It was a retrospective and single-institution study with no randomization. Furthermore, the ROTA procedure and stenting strategy were performed at the operator's discretion. A large, randomized, multicenter clinical study is required for more accurate evaluation of this interventional approach.
In conclusion, the results of the present study demonstrate that, although ROTA and DES evidently improved long-term outcomes in patients with bifurcation lesions, DM remained an independent risk factor for TLR, TL restenosis and MACE. In the future, more emphasis should be placed on the management of DM in bifurcation lesions treated with ROTA. Intensive and systemic pharmacotherapy to control neointimal formation and atherosclerosis progression may be required for treating this particular patient population.
